pI: 5.8585 |
Length (AA): 218 |
MW (Da): 23066 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 216 | 1k0w (A) | 1 | 223 | 23.00 | 0.0000062 | 1 | 1.23565 | -0.16 |
5 | 210 | 1e4c (P) | 4 | 206 | 27.00 | 0.0000063 | 1 | 1.35195 | -0.69 |
11 | 205 | 6btd (A) | 10 | 202 | 35.00 | 0 | 1 | 1.4046 | -0.86 |
11 | 204 | 4c24 (A) | 8 | 199 | 36.00 | 0 | 1 | 1.39831 | -0.84 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Dormant phase, Dormant phase. | hasan murphy |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
Ortholog group members (OG5_127052)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_54595 | Adducin-related protein 1 |
Candida albicans | CaO19.6679 | similar to bacterial aldolase |
Candida albicans | CaO19.4789 | similar to bacterial aldolase |
Candida albicans | CaO19.12253 | similar to bacterial aldolase |
Caenorhabditis elegans | CELE_F57F5.4 | Protein ADD-2, isoform B |
Caenorhabditis elegans | CELE_F39C12.2 | Protein ADD-1, isoform A |
Dictyostelium discoideum | DDB_G0282009 | alpha adducin |
Escherichia coli | b2738 | putative class II aldolase |
Escherichia coli | b2800 | L-fuculose-1-phosphate aldolase |
Echinococcus granulosus | EgrG_000830600 | adducin related protein |
Echinococcus granulosus | EgrG_000240700 | nervous system adducin |
Echinococcus granulosus | EgrG_000104300 | alpha adducin |
Echinococcus multilocularis | EmuJ_000104300 | alpha adducin |
Echinococcus multilocularis | EmuJ_000240700 | nervous system adducin |
Echinococcus multilocularis | EmuJ_000830600 | adducin related protein |
Homo sapiens | ENSG00000075340 | adducin 2 (beta) |
Homo sapiens | ENSG00000087274 | adducin 1 (alpha) |
Homo sapiens | ENSG00000148700 | adducin 3 (gamma) |
Loa Loa (eye worm) | LOAG_16242 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10542 | hypothetical protein |
Loa Loa (eye worm) | LOAG_15304 | hypothetical protein |
Mus musculus | ENSMUSG00000025026 | adducin 3 (gamma) |
Mus musculus | ENSMUSG00000029106 | adducin 1 (alpha) |
Mus musculus | 11519 | adducin 2 (beta) |
Mycobacterium tuberculosis | Rv0727c | Possible L-fuculose phosphate aldolase FucA (L-fuculose-1-phosphate aldolase) |
Mycobacterium ulcerans | MUL_3144 | ribulose-5-phosphate 4-epimerase, AraD |
Mycobacterium ulcerans | MUL_0822 | L-fuculose phosphate aldolase |
Schistosoma japonicum | Sjp_0306220 | Conserved hypothetical protein |
Schistosoma japonicum | Sjp_0030590 | Alpha-adducin, putative |
Schistosoma japonicum | Sjp_0217310 | Alpha-adducin, putative |
Schistosoma japonicum | Sjp_0054700 | Protein hu-li tai shao, putative |
Schistosoma japonicum | Sjp_0024050 | Alpha-adducin, putative |
Schistosoma japonicum | Sjp_0054710 | Alpha-adducin, putative |
Schistosoma mansoni | Smp_083040.1 | adducin related protein |
Schistosoma mansoni | Smp_014670.2 | adducin related protein |
Schistosoma mansoni | Smp_083040.2 | adducin related protein |
Schistosoma mansoni | Smp_071140 | adducin related protein |
Schistosoma mansoni | Smp_014670.1 | adducin related protein |
Schmidtea mediterranea | mk4.022678.00 | Adducin-related protein 2 |
Schmidtea mediterranea | mk4.022272.01 | |
Schmidtea mediterranea | mk4.001426.04 | Adducin-related protein 2 |
Schmidtea mediterranea | mk4.000957.00 | Adducin-related protein 1 |
Schmidtea mediterranea | mk4.000741.05 | Adducin-related protein 1 |
Schmidtea mediterranea | mk4.019881.00 | Adducin-related protein 1 |
Schmidtea mediterranea | mk4.017333.01 | |
Schmidtea mediterranea | mk4.007899.00 | Adducin-related protein 2 |
Schmidtea mediterranea | mk4.014081.00 | |
Schmidtea mediterranea | mk4.001959.01 | Adducin-related protein 1 |
Schmidtea mediterranea | mk4.022272.00 | Adducin-related protein 1 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu740 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
b2738 | Escherichia coli | non-essential | goodall |
b2800 | Escherichia coli | non-essential | goodall |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.